Sirolimus for secondary SCC prevention in renal transplantation
被引:0
|
作者:
Fabian Halleck
论文数: 0引用数: 0
h-index: 0
机构:Charité Universitätsmedizin Berlin,Department of Nephrology
Fabian Halleck
Klemens Budde
论文数: 0引用数: 0
h-index: 0
机构:Charité Universitätsmedizin Berlin,Department of Nephrology
Klemens Budde
机构:
[1] Charité Universitätsmedizin Berlin,Department of Nephrology
来源:
Nature Reviews Nephrology
|
2012年
/
8卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
A recently published study suggests that sirolimus is an attractive treatment option for the prevention of secondary skin cancer in kidney transplant recipients. However, before we think about switching all patients with a previous skin cancer (or with any other malignancy) to sirolimus, we should have a closer look at the data.